Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.04
INFU's Cash to Debt is ranked lower than
56% of the 291 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. INFU: 0.04 )
INFU' s 10-Year Cash to Debt Range
Min: 0.03   Max: No Debt
Current: 0.04

Equity to Asset 0.55
INFU's Equity to Asset is ranked higher than
62% of the 285 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.63 vs. INFU: 0.55 )
INFU' s 10-Year Equity to Asset Range
Min: 0.52   Max: 0.71
Current: 0.55

0.52
0.71
Interest Coverage 1.69
INFU's Interest Coverage is ranked lower than
54% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.61 vs. INFU: 1.69 )
INFU' s 10-Year Interest Coverage Range
Min: 0.6   Max: 9999.99
Current: 1.69

0.6
9999.99
F-Score: 6
Z-Score: 1.00
M-Score: -2.58
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 9.47
INFU's Operating margin (%) is ranked higher than
75% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.44 vs. INFU: 9.47 )
INFU' s 10-Year Operating margin (%) Range
Min: -121.45   Max: 13.67
Current: 9.47

-121.45
13.67
Net-margin (%) 2.68
INFU's Net-margin (%) is ranked higher than
68% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.65 vs. INFU: 2.68 )
INFU' s 10-Year Net-margin (%) Range
Min: -83.17   Max: 28.12
Current: 2.68

-83.17
28.12
ROE (%) 3.91
INFU's ROE (%) is ranked higher than
67% of the 283 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.68 vs. INFU: 3.91 )
INFU' s 10-Year ROE (%) Range
Min: -113.14   Max: 12.44
Current: 3.91

-113.14
12.44
ROA (%) 2.16
INFU's ROA (%) is ranked higher than
67% of the 290 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.24 vs. INFU: 2.16 )
INFU' s 10-Year ROA (%) Range
Min: -59.59   Max: 8.57
Current: 2.16

-59.59
8.57
ROC (Joel Greenblatt) (%) 26.64
INFU's ROC (Joel Greenblatt) (%) is ranked higher than
80% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.38 vs. INFU: 26.64 )
INFU' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -308.79   Max: 41.56
Current: 26.64

-308.79
41.56
Revenue Growth (%) 5.70
INFU's Revenue Growth (%) is ranked higher than
73% of the 248 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. INFU: 5.70 )
INFU' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 87.9
Current: 5.7

0
87.9
EBITDA Growth (%) 18.00
INFU's EBITDA Growth (%) is ranked higher than
89% of the 210 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.40 vs. INFU: 18.00 )
INFU' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 18
Current: 18

0
18
» INFU's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

INFU Guru Trades in

INFU Guru Trades in

Q3 2013

INFU Guru Trades in Q3 2013

Whitney Tilson 10,000 sh (New)
» More
Q4 2013

INFU Guru Trades in Q4 2013

Whitney Tilson Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with INFU



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 38.60
INFU's P/E(ttm) is ranked lower than
58% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.10 vs. INFU: 38.60 )
INFU' s 10-Year P/E(ttm) Range
Min: 2.73   Max: 98.44
Current: 38.6

2.73
98.44
P/B 1.40
INFU's P/B is ranked higher than
88% of the 278 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.77 vs. INFU: 1.40 )
INFU' s 10-Year P/B Range
Min: 0.33   Max: 1.53
Current: 1.4

0.33
1.53
P/S 0.90
INFU's P/S is ranked higher than
88% of the 292 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.60 vs. INFU: 0.90 )
INFU' s 10-Year P/S Range
Min: 0.36   Max: 6.18
Current: 0.9

0.36
6.18
PFCF 38.10
INFU's PFCF is ranked lower than
52% of the 164 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.00 vs. INFU: 38.10 )
INFU' s 10-Year PFCF Range
Min: 2.6   Max: 43.55
Current: 38.1

2.6
43.55
EV-to-EBIT 15.20
INFU's EV-to-EBIT is ranked higher than
77% of the 247 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.32 vs. INFU: 15.20 )
INFU' s 10-Year EV-to-EBIT Range
Min: 10.3   Max: 200.6
Current: 15.2

10.3
200.6

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 3.20
INFU's Price/Tangible Book is ranked higher than
70% of the 232 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. INFU: 3.20 )
INFU' s 10-Year Price/Tangible Book Range
Min: 1.8   Max: 2.88
Current: 3.2

1.8
2.88
Price/DCF (Projected) 0.80
INFU's Price/DCF (Projected) is ranked higher than
95% of the 147 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. INFU: 0.80 )
INFU' s 10-Year Price/DCF (Projected) Range
Min: 0.47   Max: 0.66
Current: 0.8

0.47
0.66
Price/Median PS Value 0.90
INFU's Price/Median PS Value is ranked higher than
72% of the 268 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. INFU: 0.90 )
INFU' s 10-Year Price/Median PS Value Range
Min: 0.55   Max: 1.19
Current: 0.9

0.55
1.19
Price/Graham Number 2.20
INFU's Price/Graham Number is ranked higher than
59% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.20 vs. INFU: 2.20 )
INFU' s 10-Year Price/Graham Number Range
Min: 1.78   Max: 1.78
Current: 2.2

Earnings Yield (Greenblatt) 6.60
INFU's Earnings Yield (Greenblatt) is ranked higher than
77% of the 226 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.40 vs. INFU: 6.60 )
INFU' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.5   Max: 9.7
Current: 6.6

0.5
9.7
Forward Rate of Return (Yacktman) 5.20
INFU's Forward Rate of Return (Yacktman) is ranked higher than
76% of the 217 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. INFU: 5.20 )
INFU' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 5.6   Max: 20.6
Current: 5.2

5.6
20.6

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Infusystem Holdings, Inc. is a provider of ambulatory infusion pumps and related services in the United States. It provides services to hospitals, oncology practices and facilities and other alternate site health care providers.
» More Articles for INFU

Headlines

Articles On GuruFocus.com
Applying Buffett’s Arbitrage Techniques to Infusystem Jul 31 2013 
InfuSystem Buyout Coming with 32% Upside Potential Jul 22 2013 
comment on INFU May 14 2013 
comment on INFU Apr 15 2013 
comment on INFU Jan 13 2013 
comment on INFU Jan 08 2013 
comment on INFU Jan 02 2013 

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide